Cardiac disturbances in diabetes mellitus

Pathophysiology

Volumn 17, Issue 2, 2010, Pages 83-88

  Takeda, Nobuakira ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac remodeling; Diabetes mellitus; Diabetic cardiomyopathy; Heart failure; Ischemic heart disease

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOTENSIN II; CALCIUM ION; LOW DENSITY LIPOPROTEIN; MITOCHONDRIAL DNA; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; REACTIVE OXYGEN METABOLITE; RENIN; VERY LOW DENSITY LIPOPROTEIN;

ADRENERGIC SYSTEM; ATHEROGENESIS; AUTONOMIC NEUROPATHY; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELLULAR DISTRIBUTION; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MICROANGIOPATHY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SARCOLEMMA; SARCOPLASMIC RETICULUM;

EID: 77649185568     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2009.03.012     Document Type: Review

References (72)

1. Rubler S., Dlugash J., Yuceoglu Y.Z., Kumral T., Branwood A.W., and Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 30 (1972) 595-602
2. Hamby R.I., Zoneraich S., and Sherman L. Diabetic cardiomyopathy. JAMA 229 (1974) 1749-1754
3. Regan T.J., Lyons M.M., Ahmed S.S., Levinson G.E., Oldewurtel H.A., Shmed M.R., and Haider B. Evidence for cardiomyopathy in familial diabetes mellitus. J. Clin. Invest. 60 (1977) 884-899
4. Cosson S., and Kevorkian J.P. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy?. Diabetes Metab. 29 (2003) 455-466
5. Fang Z.Y., Yuda S., Anderson V., Anderson V., Short L., Case C., and Marwick T.H. Echocardiographic detection of early diastolic myocardial disease. J. Am. Coll. Cardiol. 41 (2003) 611-617
6. Dutta K., Carmody M.W., Cala S.E., and Dividoff A.J. Depressed PKA activity contributes to impaired SERCA function and is linked to the pathogenesis of glucose-induced cardiomyopathy. J. Mol. Cell. Cardiol. 34 (2002) 985-996
7. Wold L.E., Dutta K., Mason M.M., Ren J., Cala S.E., Schwanke M.L., and Davidoff A.J. Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats. J. Mol. Cell. Cardiol. 39 (2005) 297-307
8. Van Hoeven K.H., and Factor S.M. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82 (1990) 848-855
9. DiBonito P., Cuomo S., Moio N., Sibilio G., Sabatini D., Quattrin S., and Capaldo B. Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration. Diabet. Med. 13 (1996) 321-324
10. Laakso M. Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J. Intern. Med. 249 (2001) 225-235
11. Nathan D.M. Long-term complications of diabetes mellitus. N. Engl. J. Med. 328 (1993) 1676-1685
12. Margolis J.R., Kannel W.S., Feinleib M., Dawber T.R., and McNamara P.M. Clinical features of unrecognized myocardial infarction-silent and asymptomatic. Eighteen year follow-up: the Framingham Study. Am. J. Cardiol. 32 (1973) 1-7
13. Vigorita V.J., Moore G.W., and Hutchins G.M. Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onset. Am. J. Cardiol. 46 (1980) 535-542
14. Waller B.F., Palumbo P.J., Lie J.T., and Roberts W.C. Status of the coronary arteries at necropsy in diabetes mellitus with onset after 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subject. Am. J. Med. 69 (1980) 498-506
15. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 29 Suppl 1 (2006) S4-S42
16. Turner R.C., Millns H., Neil H.A., Stratton I.M., Manley S.E., Matthews D.R., and Holman R.R. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 317 (1998) 693-694
17. Austin M.A., Mykkanen L., Kuusisto J., Edwards K.I., Nelson C., Haffner S.M., Pyörälä K., and Laasko M. Prospective study of small LDLs as a risk factor for non-insulin-dependent diabetes mellitus in elderly men and women. Circulation 92 (1995) 1770-1778
18. Ginsberg H.N. Diabetic dyslipidemia: basic mechanisms underlying the common hyper-triglyceridemia and low HDL cholesterol levels. Diabetes 45 Suppl (1996) 27S-30S
19. Laasko M., Lehto S., Penttila I., and Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and mobidity in patients with non-insulin-dependent diabetes. Circulation 88 (1993) 1421-1430
20. Goldschmid M.G., Barrett-Connor E., Edelstein S.L., Wingard D.L., Cohn B.A., and Herman W.H. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation 89 (1994) 991-997
21. Gousseva N., Kugathasan K., Chesterman C.N., and Khachigian L.M. Early growth response factor-1 mediates insulin-inducible vascular endothelial cell proliferation and regrowth after injury. J. Cell. Biochem. 81 (2001) 523-534
22. Price C.L., and Knight S.C. Advanced glycation: a novel outlook on atherosclerosis. Curr. Pharm. Des. 13 (2007) 3681-3687
23. Yan S.F., Harja E., Andrassy M., Fujta T., and Schmidt A.M. Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis and restenosis. J. Am. Coll. Cardiol. 48 9 Suppl 1 (2006) A47-A55
24. Kaneko M., Bucciarelli L., Hwang Y.C., Lee L., Yan S.F., Schmidt A.M., and Ramasamy R. Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury. Ann. N. Y. Acad. Sci. 1043 (2005) 702-709
25. Cipollone F., Iezzi A., Fazia M., Zucchelli M., Pini B., Cuccurullo C., DeCesare D., DeBlasis G., Muraro R., Bei R., Chiarelli F., Schmidt A.M., Cuccurullo F., and Mezzetti A. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 108 (2003) 1070-1077
26. Brazionics L., Rowley K., Jenkins A., Itsiopoulos C., and O'Dea K. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 786-791
27. Festa A., Agostino Jr. R., Tracy R.P., and Haffner S.M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 51 (2002) 1131-1137
28. Kitagawa N., Yano Y., Gabazza E.C., Bruno N.E., Araki R., Matsumoto K., Katsuki A., Hori Y., Nakatani K., Taguchi O., Sumida Y., Suzuki K., and Adachi Y. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients. Diabetes Res. Clin. Pract. 73 (2006) 150-157
29. Nordt T.K., Schneider D.J., and Sobel B.E. Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease. Circulation 89 (1994) 321-330
30. Ewing D.J., Borsey D.Q., Travis P., Bellavere F., Neilson J.M., and Clarke B.F. Abnormalities of ambulatory 24-hour heart rate in diabetic mellitus. Diabetes 32 (1983) 101-105
31. Kahn J.K., Sisson J.C., and Vinik A.I. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J. Clin. Endocrinol. Metab. 64 (1987) 751-754
32. Shimabukuro M., Chibara T., Yoshida H., Nagamine F., Komiya I., and Takasu N. Increased QT dispersion and cardiac adrenergic dysinnervation in diabetic patients with autonomic neuropathy. Am. J. Cardiol. 78 (1996) 1057-1059
33. Hattori N., Tomaki N., Hayashi T., Masuda I., Kudoh T., Tateno M., Tadamura E., Yonekura Y., Nakao K., and Konishi J. Regional abnormality of iodine-123-MIBG in diabetic hearts. J. Nucl. Med. 37 (1996) 1985-1990
34. Nagamachi S., Jinnouchi S., Nakahara H., Flores II L.G., Ohnishi T., Hoshi H., Futami S., Watanabe K., Nakatsuru K., Toshimori T., and Matsukura S. 123-MIBG myocardial scintigraphy in diabetic patients: relationship to autonomic neuropathy. Nucl. Med. Commun. 17 (1996) 621-632
35. Fein F.S., Strobeck J.E., Malhotra A., and Scheuer J. Reversibility of diabetic cardiomyopathy with insulin in rats. Circ. Res. 49 (1981) 1251-1261
36. Pierce G.N., and Dhalla N.S. Cardiac myofibrillar ATPase activity in diabetic rats. J. Mol. Cell. Cardiol. 13 (1981) 1063-1069
37. Pierce G.N., and Dhalla N.S. Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am. J. Physiol. 248 (1985) E170-E175
38. Takeda N., Dixon I.M.C., Hata T., Elimban V., Shah K.R., and Dhalla N.S. Sequence of alterations in subcellular dysfunction in diabetes. Diabetes Res. Clin. Pract. 30 Suppl (1996) S113-S122
39. Dillman W.H. Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes 29 (1980) 579-582
40. Takeda N., Nakamura I., Hatanaka T., Ohkubo T., and Nagano M. Myocardial mechanical and myosin isoenzyme alterations in streptozotocin-diabetic rats. Jpn. Heart J. 29 (1988) 455-463
41. Caforio A.L.P., Grazzini M., Mann J.M., Keeling P.J., Bottazzo G.F., MacKenna W.J., and Schiaffino S. Identification of α- and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85 (1992) 1734-1742
42. Mercadier J.J., Bouveret P., Gorza L., Schiaffino S., Clark W.A., Zak R., and Swinghedauw B. Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ. Res. 53 (1983) 52-62
43. Takeda N., Rupp H., Fenchel G., Hoffmeister H.E., and Jacob R. Relationship between the myofibrillar ATPase activity of human biopsy material and hemodynamic parameters. Jpn. Heart J. 26 (1985) 909-922
44. Takeda N., Ota Y., Tanaka Y., Shikata C., Hayashi Y., Nemoto S., Tanamura A., Iwai T., and Nakamura I. Myocardial adaptive changes and damage in ischemic heart disease. Ann. N. Y. Acad. Sci. 793 (1996) 282-288
45. Liu X., Takeda N., and Dhalla N.S. Myosin light-chain phosphorylation in diabetic cardiomyopathy in rats. Metabolism 46 (1997) 71-75
46. Liu X., Takeda N., and Dhalla N.S. Troponin I phosphorylation in heart homogenate from diabetic rat. Biochem. Biophys. Acta 1316 (1996) 78-84
47. Ganguly P.K., Pierce G.N., Dhalla K.S., and Dhalla N.S. Defective sarcoplasmic ventricular calcium transport in diabetic cardiomyopathy. Am. J. Physiol. 244 (1983) E528-E536
48. Lopaschuk G.D., Tahiliani A.G., Vadlamudi R.V.S.V., Katz S., and McNeil J.H. Cardiac sarcoplasmic reticulum function in insulin- or creatine-treated diabetic rats. Am. J. Physiol. 245 (1983) H969-H976
49. 2+ pump activity during diabetes mellitus. Am. J. Physiol. 525 (1987) H540-H544
50. 2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am. J. Physiol. 253 (1987) E202-E207
51. + ATPase activity in diabetic rat heart. Am. J. Physiol. 245 (1983) C241-C247
52. Pierce G.N., Kutryk M.J.B., and Dhalla N.S. Alterations in calcium binding and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 5412-5416
53. Ganguly P.K., Dhalla K.S., Innes I.R., Beamish R.E., and Dhalla N.S. Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ. Res. 59 (1986) 684-693
54. Gotzsche O. The adrenergic β-receptor adenylate cyclase system in heart and lymphocytes from streptozotocin-diabetic rats. Diabetes 32 (1983) 1110-1116
55. Christlieb A.R., Kaldany A., and D'Elia J.A. Plasma rennin activity and hypertension in diabetes mellitus. Diabetes 25 (1976) 969-974
56. Duntas L., Keck F.S., Haug C., Hetzel W., Wolf C.F., Rosenthal J., and Pfeiffer E.F. Serum angiotensin-converting enzyme activity and active rennin plasma concentrations in insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 16 (1992) 203-208
57. Hollenberg N.K., Stevanovic R., Agarwal A., Lansang M.C., Price D.A., Laffel L.M., Williams G.H., and Fisher N.D. Plasma aldosterone concentration in the patient with diabetes mellitus. Kidney Int. 65 (2004) 1435-1439
58. Khatter J.C., Sadi P., Zhang M., and Hoeschen R.J. Myocardial receptors in diabetic rat. Ann. N. Y. Acad. Sci. 793 (1996) 466-472
59. Sechi L.A., Griffin C.A., and Schamelan M. The cardiac rennin-angiotensin system in STZ-induced diabetes. Diabetes 43 (1994) 1180-1184
60. Funakoshi Y., Ichiki T., Ito K., and Takeshita A. Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 34 (1999) 118-125
61. Han Y., Runge M.S., and Brasier A.R. Angiotensin II induces IL-6 transcription in vascular smooth muscle cells through pleiotropic activation of NF-κB transcription factors. Circ. Res. 84 (1999) 695-703
62. 1 receptor regulation. Circulation 105 (2002) 530-536
63. Gillery P., Monboisse J.C., Maquart F.X., and Borel J.P. Glycation of proteins as a source of superoxide. Diabetes Metab. 14 (1988) 25-30
64. Hunt J.V., Smith C.C.T., and Wolff S.P. Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39 (1990) 1420-1424
65. Wolff S.P., and Dean R.T. Glucose auto-oxidation and protein modification. The potential role of 'autooxidative glycosylation' in diabetes. Biochem. J. 245 (1987) 243-250
66. Aronson D., and Rayfield E.J. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc. Diabetol. 1 (2002) 1
67. Kakkar R., Kalta J., Mantha V., and Prasad K. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol. Cell. Biochem. 151 (1995) 113-119
68. Mak D.H.F., Ip S.P., Li P.C., Poon M.K.T., and Ko K.M. Alterations in tissue glutathione antioxidant system in streptozotocin induced diabetic rats. Mol. Cell. Biochem. 162 (1996) 153-158
69. Rosen P., Ballhausen T., Bloch W., and Adicks K. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 38 (1995) 1157-1168
70. Bellin C., de Wiza D.H., Wiernsperger N.F., and Rösen P. Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin. Horm. Metab. Res. 38 (2006) 732-739
71. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur. J. Clin. Invest. 34 (2004) 785-796
72. Takeda N., Tanamura A., Iwai T., Nakamura I., Kato M., Ohkubo T., and Noma K. Mitochondrial DNA deletion in human myocardium. Mol. Cell. Biochem. 119 (1993) 105-108